agena-bioscience-logo
  • Technology
  • Applications
  • Resources
  • Support
  • Company
  • Contact
EN - Global CN - 中国

menu

agena-bioscience-logo agena-bioscience-logo Close
  • Home
  • Technology
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Mutation Profiling
    • Hereditary Genetics
    • Methylation
    • Sample Integrity
    • Specimen Validity
  • Services
    • Assays by Agena
    • Certified Service Providers
  • Resources
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal
  • Home
  • Technology
  • Applications
    • Pharmacogenetics
    • Mutation Profiling
    • Liquid Biopsy
    • Hereditary Genetics
    • Methylation
    • Sample Integrity
    • Specimen Validity
  • Services
    • Assays by Agena
    • Certified Service Providers
  • Resources
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal

Phone: (858) 882-2800

Home / Resources / Publication Library

Search Results for: Mutation Profiling

Search All publications

How recent?
  • Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis
  • Clinical Application of Fusion Gene Detection Using Next-Generation Sequencing and the NanoString Technology
  • Crossing Borders: A Systematic Review with Quantitative Analysis of Genetic Mutations of Carcinomas of the Biliary Tract
  • Molecular Diagnostics for Lung Cancer
  • RAS Mutation in Mucinous Carcinoma of the Ovary
  • The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity
  • Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
  • Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p. L747P and p. L747S mutations
  • Clinical features and progression pattern of acquired T790M positive compared with T790M negative EGFR mutant Non-Small Cell Lung Cancer: catching tumor and clinical heterogeneity over time through liquid biopsy
  • Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes
«...1020...2728293031...4050...»
Products
  • Technology
  • Applications
  • Custom Assays
Resources
  • Product Literature
  • Publication Library
  • ISO Certifications
  • Patents
    Support
    • Support Contacts
    • Service Plans
    • Certified Service Providers
    • Distributors
    • Customer Support Portal
Company
  • About Us
  • Careers
  • Contact
footer-logo
Agena Bioscience

4755 Eastgate Mall,
San Diego, CA 92121

(877) 443-6663

With exception of the MassARRAY Dx, all other products are For Research Use Only. Not for use in diagnostic procedures.
© 2020-2025 Agena Bioscience, Inc. All rights reserved. Agena Bioscience is a subsidiary of Mesa Labs, Inc.

  • footer-mesalabs-logo
  • footer-protein-logo
  • footer-gke-logo
  • Privacy Policy
  • Website Terms & Conditions
  • Product Terms & Conditions
  • Warranty